eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| thymic tumor | ||||
| Disease ID | 1384 |
|---|---|
| Disease | thymic tumor |
| Definition | Tumors or cancer of the THYMUS GLAND. |
| Synonym | neopl thymic neopl thymus neoplasm of the thymus neoplasm of thymus neoplasm of thymus (disorder) neoplasm, thymic neoplasm, thymus neoplasms, thymic neoplasms, thymus thymic neopl thymic neoplasm thymic neoplasms thymic tumors thymus neopl thymus neoplasm thymus neoplasms thymus neoplasms [disease/finding] thymus tumor thymus tumors thymus--tumors tumor of the thymus tumor of thymus tumor, thymic tumor, thymus tumors, thymic tumors, thymus tumour of thymus tumour thymus |
| Orphanet | |
| DOID | |
| UMLS | C3714644 |
| MeSH | |
| SNOMED-CT | |
| Comorbidity | UMLS | Disease | Sentences' Count(Total Sentences:10) C0040100 | thymomas | 2 C0010481 | cushing's syndrome | 2 C0409974 | lupus erythematosus | 1 C0020550 | hyperthyroidism | 1 C0334121 | inflammatory pseudotumor | 1 C0040100 | thymoma | 1 C0019829 | hodgkin lymphoma | 1 C0024141 | systemic lupus erythematosus | 1 C0026896 | myasthenia gravis | 1 C0027819 | neuroblastoma | 1 |
| Curated Gene | (Waiting for update.) |
| Inferring Gene | (Waiting for update.) |
| Text Mined Gene | (Waiting for update.) |
| Locus | (Waiting for update.) |
| Disease ID | 1384 |
|---|---|
| Disease | thymic tumor |
| Integrated Phenotype | HPO | Name(Total Integrated Phenotypes:21) HP:0001892 | Abnormal bleeding HP:0002463 | Language impairment HP:0100634 | Neuroendocrine neoplasm HP:0002094 | Dyspnea HP:0003473 | Fatigable weakness HP:0002721 | Immunodeficiency HP:0100521 | Neoplasm of the thymus HP:0100721 | Mediastinal lymphadenopathy HP:0002015 | Dysphagia HP:0001695 | Cardiac arrest HP:0002960 | Autoimmunity HP:0002516 | Increased intracranial pressure HP:0006597 | Diaphragmatic paralysis HP:0100749 | Chest pain HP:0002315 | Headache HP:0002961 | Dysgammaglobulinemia HP:0012735 | Cough HP:0000508 | Ptosis HP:0001701 | Pericarditis HP:0100540 | Palpebral edema HP:0000969 | Edema |
| Text Mined Phenotype | HPO | Name | Sentences' Count(Total Phenotypes:7) HP:0030731 | Carcinoma | 2 HP:0100570 | Carcinoid tumor | 1 HP:0012189 | Hodgkin disease | 1 HP:0003006 | Neuroblastoma | 1 HP:0100522 | Thymoma | 1 HP:0002725 | Systemic lupus erythematosus | 1 HP:0000836 | Overactive thyroid | 1 |
| Disease ID | 1384 |
|---|---|
| Disease | thymic tumor |
| Manually Symptom | (Waiting for update.) |
| Text Mined Symptom | (Waiting for update.) |
Manually Genotype(Total Text Mining Genotypes:0) |
|---|
| (Waiting for update.) |
Text Mining Genotype(Total Genotypes:0) | |
|---|---|
| (Waiting for update.) | |
All Snps(Total Genotypes:0) | |
|---|---|
| (Waiting for update.) | |
GWASdb Annotation(Total Genotypes:0) | |
|---|---|
| (Waiting for update.) | |
GWASdb Snp Trait(Total Genotypes:0) | |
|---|---|
| (Waiting for update.) | |
Mapped by lexical matching(Total Items:4) | ||||
|---|---|---|---|---|
| HP ID | HP Name | MP ID | MP Name | Annotation |
| HP:0100540 | Palpebral edema | MP:0001786 | skin edema | accumulation of an excessive amount of fluid in the skin layers or just underneath the skin |
| HP:0001892 | Abnormal bleeding | MP:0005606 | increased bleeding time | greater than the normal duration of blood flow after skin puncture; indicative of platelet and capillary function |
| HP:0003473 | Fatigable weakness | MP:0000747 | muscle weakness | loss of muscle strength |
| HP:0006597 | Diaphragmatic paralysis | MP:0000755 | hindlimb paralysis | loss of power of voluntary movement in the muscles of the hindlimb through injury or disease of it or its nerve supply |
Mapped by homologous gene(Total Items:19) | ||||
|---|---|---|---|---|
| HP ID | HP Name | MP ID | MP Name | Annotation |
| HP:0003473 | Fatigable weakness | MP:0013785 | abnormal mammary gland bud morphology | any structural anomaly of the morphologically distinct bulb of epithelial cells formed once each mammary placode expands and invaginates into the underlying mesenchyme; in mouse embryos at E12.5, each epithelial bud with its contiguous mesenchyme is eleva |
| HP:0012735 | Cough | MP:0014185 | cerebellum atrophy | acquired diminution of the size of the cerebellum associated with wasting as from death and reabsorption of cells, diminished cellular proliferation, decreased cellular volume, pressure, ischemia, malnutrition, reduced function or malfunction, or hormonal |
| HP:0002094 | Dyspnea | MP:0014185 | cerebellum atrophy | acquired diminution of the size of the cerebellum associated with wasting as from death and reabsorption of cells, diminished cellular proliferation, decreased cellular volume, pressure, ischemia, malnutrition, reduced function or malfunction, or hormonal |
| HP:0002463 | Language impairment | MP:0020329 | decreased capillary density | reduction in the number of capillaries in a given cross-sectional area of a tissue |
| HP:0000969 | Edema | MP:0020154 | impaired humoral immune response | impaired response of the immune system that mediates secreted antibodies produced in B cells |
| HP:0002721 | Immunodeficiency | MP:0020316 | decreased vascular endothelial cell proliferation | decrease in the expansion rate of any vascular endothelial cell population by cell division |
| HP:0002960 | Autoimmunity | MP:0020220 | decreased tear production | decreased production of the amount of fluid produced in the eye |
| HP:0100721 | Mediastinal lymphadenopathy | MP:0014169 | decreased brown adipose tissue mass | decreased physical bulk or volume of brown adipose tissue |
| HP:0100749 | Chest pain | MP:0020154 | impaired humoral immune response | impaired response of the immune system that mediates secreted antibodies produced in B cells |
| HP:0002315 | Headache | MP:0020137 | decreased bone mineralization | decrease in the rate at which minerals are deposited into bone |
| HP:0002516 | Increased intracranial pressure | MP:0020215 | impaired blood coagulation | impaired ability of the blood to clot |
| HP:0000508 | Ptosis | MP:0020321 | increased vascular endothelial cell apoptosis | increase in the timing or the number of vascular endothelial cells undergoing programmed cell death |
| HP:0001701 | Pericarditis | MP:0011405 | tubulointerstitial nephritis | diffuse or local inflammation and edema of the interstitial tissue of the kidney, including the renal tubules; usually secondary to drug sensitization, systemic infection, graft rejection, or autoimmune disease |
| HP:0002015 | Dysphagia | MP:0020329 | decreased capillary density | reduction in the number of capillaries in a given cross-sectional area of a tissue |
| HP:0002961 | Dysgammaglobulinemia | MP:0013501 | increased fibroblast apoptosis | increase in the timing or the number of fibroblast cells undergoing programmed cell death |
| HP:0001892 | Abnormal bleeding | MP:0020138 | delayed bone mineralization | late onset of the process by which minerals are deposited into bone |
| HP:0006597 | Diaphragmatic paralysis | MP:0014074 | increased brain glycogen level | greater than the normal concentration of a readily converted carbohydrate reserve in brain |
| HP:0100540 | Palpebral edema | MP:0020137 | decreased bone mineralization | decrease in the rate at which minerals are deposited into bone |
| HP:0001695 | Cardiac arrest | MP:0013578 | abnormal stomach glandular region morphology | any structural anomaly of the distinct glandular stomach area which in rodents is demarcated from the non-glandular forestomach by the limiting ridge (margo plicatus); the glandular stomach is connected to the small intestine (duodenum); the wall of the g |
| Disease ID | 1384 |
|---|---|
| Disease | thymic tumor |
| Case | (Waiting for update.) |